Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology

• Main Authors: Hangsheng Bao (Author), Huizhi Guo (Author), Zongquan Feng (Author), Xin Li (Author)
• Formato: Livro
• Publicado em: BMC, 2020-07-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Xianlinggubao formula (XLGB), a Chinese State Food and Drug Administration-permitted traditional Chinese herbal medicine, has been extensively used to treat osteoporosis. Although XLGB was shown to improve bone mass in ovariectomized rats and clinically alleviate osteoporosis sym...